(b) Univaried description of adherence and independent continuous variables. Adherence is defined as taking more than 80% of medication

Continuous variables	Age (yrs) of adherent patients	Age (yrs) of nonadherent patients	Number of clinic visits per year of adherent patients	Number of clinic visits per year of nonadherent patients	Duration of disease (yrs) of those adherence	Duration of disease (yrs) of those nonadherent
Immunomodulators
n observations	91	69	91	69	91	69
Median	11.9	11.5	3	2	2.3	3.64
IQR	9.06 to 13.80	8.80 to 13.32	1.00 to 4.00	1.00 to 4.00	1.90 to 4.35	1.30 to 7.25
Mean	10.95	10.59	2.88	2.79	2.88	2.8
std. Dev.	3.79	4.07	2.11	1.91	2.11	1.91
5-ASA
n observations	37	35	37	35	37	35
Median	13.18	10.99	2	2	2.4	2.92
IQR	7.47, 14.45	6.88, 13.18	1.00 to 3.00	1.00 to 4.00	2.00 to 3.25	1.88 to 4.43
Mean	11.12	10.46	2.7	2.69	3.26	3.63
std. Dev.	4.87	3.74	2.25	2.21	2.25	2.6
Biologics
n observations	65	15	65	15	65	15
Median	11.20	11.19	2.00	3.00	3.76	5.52
IQR	6.75 to 13.37	9.45 to 13.05	1.00 to 4.00	2.00 to 4.00	2.05 to 6.80	2.30 to 6.04
Mean	10.29	11.02	2.9	2.8	4.77	4.62
std. Dev.	4.14	2.48	2.06	1.47	3.26	1.98
Blood work
n observations	102	148	102	148	102	148
Median	12.27	10.7	2.5	2	2.73	3.7
IQR	8.36 to 13.73	7.10 to 13.05	2.00 to 4.00	1.00 to 3.00	1.90 to 4.51	2.2 to 6.80
Mean	11.12	9.84	2.9	2.21	3.45	4.71
std. Dev.	3.9	4.01	1.89	1.82	2.33	3.03